Related Experiment Video
Updated: May 10, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
ATP interacts with the CPVT mutation-associated central domain of the cardiac ryanodine receptor
Lynda Blayney1, Konrad Beck, Ewan MacDonald
1Institute of Molecular and Experimental Medicine, Cardiff University, Cardiff, UK. blayney@cf.ac.uk
Background:
This study was designed to determine whether the cardiac ryanodine receptor (RyR2) central domain, a region associated with catecholamine polymorphic ventricular tachycardia (CPVT) mutations, interacts with the RyR2 regulators, ATP and the FK506-binding protein 12.6 (FKBP12.6).
Methods:
Wild-type (WT) RyR2 central domain constructs (G(2236)to G(2491)) and those containing the CPVT mutations P2328S and N2386I, were expressed as recombinant proteins. Folding and stability of the proteins were examined by circular dichroism (CD) spectroscopy and guanidine hydrochloride chemical denaturation.
Results:
The far-UV CD spectra showed a soluble stably-folded protein with WT and mutant proteins exhibiting a similar secondary structure. Chemical denaturation analysis also confirmed a stable protein for both WT and mutant constructs with similar two-state unfolding. ATP and caffeine binding was measured by fluorescence spectroscopy. Both ATP and caffeine bound with an EC50 of ~200-400μM, and the affinity was the same for WT and mutant constructs. Sequence alignment with other ATP binding proteins indicated the RyR2 central domain contains the signature of an ATP binding pocket. Interaction of the central domain with FKBP12.6 was tested by glutaraldehyde cross-linking and no association was found.
Conclusions:
The RyR2 central domain, expressed as a 'correctly' folded recombinant protein, bound ATP in accord with bioinformatics evidence of conserved ATP binding sequence motifs. An interaction with FKBP12.6 was not evident. CPVT mutations did not disrupt the secondary structure nor binding to ATP.
General Significance:
Part of the RyR2 central domain CPVT mutation cluster, can be expressed independently with retention of ATP binding.
Insights
The cardiac ryanodine receptor central domain binds ATP, and CPVT mutations do not affect this interaction or protein structure. FKBP12.6 does not associate with this RyR2 domain.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Protein Structure and Function
Background:
- The cardiac ryanodine receptor (RyR2) central domain is implicated in catecholamine polymorphic ventricular tachycardia (CPVT).
- Understanding RyR2 interactions with ATP and FKBP12.6 is crucial for CPVT pathogenesis.
Purpose of the Study:
- To investigate the interaction of the RyR2 central domain with ATP and FKBP12.6.
- To determine the effect of CPVT mutations on RyR2 central domain structure and function.
Main Methods:
- Recombinant expression of wild-type and CPVT mutant RyR2 central domain constructs.
- Circular dichroism spectroscopy and chemical denaturation for protein folding and stability assessment.
- Fluorescence spectroscopy for ATP and caffeine binding assays; glutaraldehyde cross-linking for FKBP12.6 interaction studies.
Main Results:
- Wild-type and CPVT mutant RyR2 central domains exhibited stable, correctly folded structures with similar secondary structures.
- ATP and caffeine binding occurred with similar affinities (~200-400μM EC50) for both wild-type and mutant constructs.
- Bioinformatics analysis suggested an ATP binding pocket within the RyR2 central domain; no interaction with FKBP12.6 was detected.
Conclusions:
- The RyR2 central domain, when expressed as a recombinant protein, retains ATP binding capacity, supported by sequence motifs.
- CPVT mutations do not compromise the secondary structure or ATP binding of the RyR2 central domain.
- The RyR2 central domain does not appear to interact with FKBP12.6.
Related Concept Videos
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
ATP Synthase: Mechanism
The ADP/ATP Carrier Protein
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
ATP Synthase: Structure

